WASHINGTON, D.C. – The FLCCC is grateful for the passage of House Bill 73 (HB73) that passed the Ohio House of Representatives yesterday with bipartisan support. The bill will now go to the Ohio Senate for deliberations and will hopefully be signed into law by Governor DeWine soon.
We would like to acknowledge the vision and leadership of Representative Gross who introduced HB73 earlier this year. The FLCCC would also like to thank the Ohio House of Representatives for their bipartisan support to protect doctors and healthcare professionals from unwarranted policies that prevent patient access to repurposed medications.
In April of this year, Paul Marik, M.D., co-founder and chief scientific officer of the FLCCC, testified before the Health Provider Services Committee of the Ohio State House in support of HB73. In his testimony, Dr. Marik discussed the importance of HB73 in protecting doctors when prescribing repurposed medications based on their knowledge and training and the necessity of practicing medicine without improper interference of state agencies following politically driven edicts.
“The Ohio House passing HB73 is a great step forward in ensuring access to important treatments that were arbitrarily restricted during the pandemic,” said Paul Marik, M.D., co-founder and chief scientific officer of the FLCCC. “Allowing for baseless restrictions on prescribing repurposed medications is basically telling doctors that we need to take our orders from inexperienced bureaucrats instead of make treatment decisions based on our training and expertise. Many of the intrusive policies made during the pandemic did nothing to protect public health while they degraded the practice of medicine to be something that is done out of fear rather than to heal our patients in the best way we know how.”
A copy of Dr. Marik’s testimony can be found here: https://covid19criticalcare.com/wp-content/uploads/2023/04/MARIK-TESTIMONY-OHIO-HB-73-4-25-2023.pdf
A copy of the bill and its status can be found here: https://legiscan.com/OH/bill/HB73/2023
About the Front Line COVID-19 Critical Care Alliance
The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned critical care physicians and scholars with the academic support of allied physicians from around the world. FLCCC’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness including the I-RECOVER protocols for “Long COVID” and Post Vaccine Syndrome. For more information: www.FLCCC.net